Strategy discovered for fighting persistent bacterial infections

Mar 23, 2009

Researchers at National Jewish Health have discovered a promising strategy for destroying the molecular scaffolding that can make Pseudomonas bacterial infections extremely difficult to treat in cystic fibrosis patients, wearers of contact lenses, and burn victims. Jerry Nick, MD, Associate Professor of Medicine at National Jewish Health, and his colleagues report in the April 2009 issue of The Journal of Medical Microbiology that a long string of aspartic acid molecules disrupts the molecular bonds that hold together the structure supporting Pseudomonas biofilms.

"Once a bacterial community forms a biofilm it becomes much more difficult to treat," said Dr. Nick. "We think our discovery will pave the way for more effective treatment of Pseudomonas aeruginosa infections, which can wreak so much havoc in cystic ."

Biofilms are a form of bacterial colony in which attach to and live within an , where medications and the immune system have difficulty reaching them. As a result, these infections become very difficult to treat effectively. Pseudomonas biofilms form and cause lung damage in most patients as they grow older. Pseudomonas biofilms can also form on the corneas of contact lens wearers, and in wounds and burns.

Dr. Nick and his colleagues previously showed that formation of Pseudomonas aeruginosa biofilms is enhanced by the remains of known as neutrophils, which accumulate in vast numbers to the site of infection, then die and spill their contents. Pseudomonas builds the extracellular matrix from neutrophils' DNA, the actin structural molecules, and histones, the molecules around which DNA normally wraps inside the cell nucleus.

DNase, an enzyme that breaks long strands of DNA, is already used to help thin the thick mucus that plagues cystic fibrosis patients. Dr. Nick believes it may also break up the Pseudomonas biofilms. But it is clearly not enough, because Pseudomonas biofilms remain one of the most vexing problems for cystic fibrosis patients as they age.

Dr. Nick and his colleagues thought that a negatively charged molecule might help break up the biofilms by bonding to the positively charged histones and preventing them from contributing to the molecular scaffolding, and by breaking apart actin bundles. So, they added aspartic , long strings of the negatively charged molecules, to cell cultures of Pseudomonas aeruginosa and neutrophils.

In one experiment, a 48-hour-old Pseudomonas biofilm was reduced by 42 percent when exposed to DNase for 10 minutes. The aspartic acid polymer alone could not reduce the density of the 48-hour-old biofilm. But when both DNase and the aspartic acid polymer were applied to the biofilm, it was reduced by 78 percent. Several other experiments with varying doses and exposure times of DNase and the aspartic acid polymer on different Pseudomonas strains and biofilms had similar results.

"The DNase and aspartic acid worked together synergistically to break down the biofilm," said Quinn Parks, PhD, lead author on the research paper. "We are now experimenting with different aspartic acid polymers to find the most effective ones. This may be an important new therapeutic strategy for combating Pseudomonas infections."


Source: National Jewish Medical and Research Center

Explore further: Technology translation engine launches 'Organs-on-Chips' company

add to favorites email to friend print save as pdf

Related Stories

No hiding place for infecting bacteria

Mar 16, 2009

Scientists in Colorado have discovered a new approach to prevent bacterial infections from taking hold. Writing in the Journal of Medical Microbiology, Dr Quinn Parks and colleagues describe how they used enzymes against produc ...

Protein opens hope of treatment for cystic fibrosis patients

Sep 11, 2008

Scientists have finally identified a direct role for the missing protein that leaves cystic fibrosis patients open to attack from lung-damaging bacteria, the main reason most of them die before their 35th birthday, scientists ...

Gallium: A new antibacterial agent?

Mar 16, 2007

New antibacterial strategies are needed because more and more bacteria are antibiotic resistant and because antibiotics are not effective at eradicating chronic bacterial infections. One approach to developing new antibacterial ...

Research promising for cystic fibrosis

Mar 18, 2008

New University of Toronto research holds promise for developing innovative therapies against cystic fibrosis and may also serve as a model for future therapies against the HIV virus.

Recommended for you

Diet affects men's and women's gut microbes differently

8 minutes ago

The microbes living in the guts of males and females react differently to diet, even when the diets are identical, according to a study by scientists from The University of Texas at Austin and six other institutions published ...

Researchers explore what happens when heart cells fail

1 hour ago

Through a grant from the United States-Israel Binational Science Foundation, Biomedical Engineering Associate Professor Naomi Chesler will embark upon a new collaborative research project to better understand ...

Stem cells from nerves form teeth

3 hours ago

Researchers at Karolinska Institutet in Sweden have discovered that stem cells inside the soft tissues of the tooth come from an unexpected source, namely nerves. These findings are now being published in the journal Nature and co ...

User comments : 0